Omega Therapeutics Inc

General ticker "OMGA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $80.5M (TTM average)

Omega Therapeutics Inc does not follow the US Stock Market performance with the rate: -32.6%.

Estimated limits based on current volatility of 6.7%: low 0.01$, high 0.02$

Factors to consider:

  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.34$, 3.95$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.14$, 3.35$]

Financial Metrics affecting the OMGA estimates:

  • Negative: Non-GAAP EPS, $ of -1.81 <= 0.04
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -1.69 <= 0.15
  • Negative: Operating profit margin, % of -0.97 <= 0
  • Positive: Investing cash flow per share, $ of 0.88 > -0.09
  • Positive: Inventory ratio change, % of -0.86 <= -0.01

Similar symbols

Short-term OMGA quotes

Long-term OMGA plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.14MM $2.07MM $3.09MM
Operating Expenses $66.18MM $104.84MM $103.36MM
Operating Income $-66.03MM $-102.77MM $-100.26MM
Non-Operating Income $-2.25MM $0.07MM $2.83MM
R&D Expense $47.87MM $81.17MM $77.17MM
Income(Loss) $-68.28MM $-102.70MM $-97.43MM
Profit(Loss)* $-69.16MM $-102.64MM $-97.43MM
Stockholders Equity $200.63MM $105.97MM $58.02MM
Inventory $0.26MM $41.15MM $0.30MM
Assets $233.33MM $146.00MM $204.37MM
Operating Cash Flow $-57.61MM $-98.52MM $-91.51MM
Capital expenditure $1.47MM $1.38MM $2.87MM
Investing Cash Flow $-40.40MM $-18.06MM $47.52MM
Financing Cash Flow $261.54MM $0.71MM $41.82MM
Earnings Per Share** $-1.45 $-2.14 $-1.80

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.